Jiang Cao

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Peritoneal Dialysis

Acute Lymphoblastic Leukemia

Multiple Myeloma

Top Venues

Nature communications

American journal of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuekun Qi, Hujun Li, Kunming Qi, Feng Zhu, Hai Cheng, Wei Chen, Zhiling Yan, Depeng Li, Wei Sang, Xiaoming Fei, Weiying Gu, Yuqing Miao, Hongming Huang, Ying Wang, Tingting Qiu, Jianlin Qiao, Bin Pan, Ming Shi, Gang Wang, Zhenyu Li, Junnian Zheng, Kailin Xu, Jiang Cao
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy. American journal of hematology (2024)
Ning Guo, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Jun-Nian Zheng, Jiang Cao
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nature communications 15 (1) (2024)
Ning Guo, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Jun-Nian Zheng, Jiang Cao
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nature communications 15 (1) (2024)
Ning Guo, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Jun-Nian Zheng, Jiang Cao
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nature communications 15 (1) (2024)
Ning Guo, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Jun-Nian Zheng, Jiang Cao
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nature communications 15 (1) (2024)
Ning Guo, Jiaojiao Wang, Hongming Huang, Dan Liu, Hai Cheng, Xu Wang, Wei Chen, Zhiling Yan, Wei Sang, Kunming Qi, Depeng Li, Feng Zhu, Zhenyu Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Xiaoming Fei, Weiying Gu, Yuqing Miao, Kailin Xu, Jun-Nian Zheng, Jiang Cao
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial. Nature communications 15 (1) (2024)
Jieyun Xia, Hujun Li, Zhiling Yan, Dian Zhou, Ying Wang, Yuekun Qi, Jiang Cao, Depeng Li, Hai Cheng, Wei Sang, Feng Zhu, Haiying Sun, Wei Chen, Kunming Qi, Dongmei Yan, Tingting Qiu, Jianlin Qiao, Ruosi Yao, Yang Liu, Xue Wang, Yanlei Zhang, Shuixiu Peng, Chih-Hua Huang, Junnian Zheng, Zhenyu Li, Alex H Chang, Kailin Xu
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yuekun Qi, Mingfeng Zhao, Yongxian Hu, Ying Wang, Ping Li, Jiang Cao, Ming Shi, Jiaqi Tan, Meng Zhang, Xia Xiao, Jieyun Xia, Sha Ma, Jianlin Qiao, Zhiling Yan, Hujun Li, Bin Pan, Wei Sang, Depeng Li, Zhenyu Li, Jianfeng Zhou, He Huang, Aibin Liang, Junnian Zheng, Kailin Xu
Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL. Blood 139 (23) (2022)
Ming Shi, Li Li, Shiyuan Wang, Hai Cheng, Wei Chen, Wei Sang, Kunming Qi, Zhenyu Li, Gang Wang, Huizhong Li, Jianping Lan, Jinqi Huang, Xiaoming Fei, Min Yu, Fei Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Guangjun Jing, Junnian Zheng, Robert Peter Gale, Kailin Xu, Jiang Cao
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia. American journal of hematology 97 (6) (2022)
Kailin Xu, Jiang Cao, Weiying Gu, Ming Shi, Jianping Lan, Zhiling Yan, Lai Jin, Jieyun Xia, Sha Ma, Yang Liu, Hujun Li, Bin Pan, Wei Chen, Xiaoming Fei, Chunling Wang, Xiaobao Xie, Liang Yu, Gang Wang, Huizhong Li, Guangjun Jing, Hai Cheng, Feng Zhu, Haiying Sun, Wei Sang, Depeng Li, Zhenyu Li, Junnian Zheng
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (20) (2022)
Shiyuan Wang, Xue Wang, Chunying Ye, Hai Cheng, Ming Shi, Wei Chen, Kunming Qi, Gang Wang, Qingyun Wu, Lingyu Zeng, Zhenyu Li, Guangjun Jing, Junnian Zheng, Kailin Xu, Jiang Cao
Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia. American journal of hematology 96 (5) (2021)
Huihui Zhang, Fanlin Li, Jiang Cao, Xin Wang, Hai Cheng, Kunming Qi, Gang Wang, Kailin Xu, Junnian Zheng, Yang-Xin Fu, Xuanming Yang
A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity. Science translational medicine 13 (578) (2021)
Fei Hong, Ming Shi, Jiang Cao, Ying Wang, Yanqing Gong, Hui Gao, Zhenyu Li, Junnian Zheng, Lingyu Zeng, Aili He, Kailin Xu
Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia. Journal of cellular and molecular medicine 25 (24) (2021)
Hao Feng, Jianlin Qiao, Ningning Ding, Wei Chen, Kunming Qi, Xiuying Pan, Jiang Cao, Kailin Xu
Sjögren's Syndrome Complicated by Myeloid/Natural Killer Cell Precursor Acute Leukemia: Case Report and Review of the Literature. Case reports in hematology 2016 (2016)